Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
2.940
+0.170 (6.14%)
At close: Nov 11, 2026, 4:00 PM EST
2.940
0.00 (0.00%)
Pre-market: Nov 12, 2026, 4:05 AM EST
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $3.95 million as of November 11, 2026. It is the 45,704th most valuable company in the world and the 6,051st biggest in the United States. Its market cap has decreased by 87.74% in one year.
Market Cap
3.95M
Enterprise Value
2.37M
1-Year Change
-87.74%
Global Rank
Country Rank
#6,051 United States
Category
ChartMarket Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $3.95M, a decrease of -98.86%. That is a compound annual growth rate of -55.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 3.95M | -76.08% |
| Dec 31, 2025 | 16.51M | -79.39% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 4.12M |
| GRI Bio | 4.11M |
| Creative Medical Technology Holdings | 4.09M |
| PharmaCyte Biotech | 3.85M |
| Traws Pharma | 3.48M |
| Cadrenal Therapeutics | 3.48M |
| KALA BIO | 3.19M |
| Aptevo Therapeutics | 3.17M |